Kezar Life Sciences, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €18.74M
    R&D expenses
    €46.63M
    EBITDA
    -€60.22M
    D&A
    €664.54K
    EBIT
    -€65.37M
    Interest expenses
    €1.24M
    EBT
    -€61.10M
    Tax expenses
    €0.00
    Net income
    -€61.10M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€872.53K
    Changes in working capital
    €2.74M
    Operating cash flow
    -€55.50M
    Capex
    €31.93K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €62.95M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€18.12K
    Debt repayment
    €0.00
    Other financing cash flow
    -€2.13M
    Net financing cash flow
    -€2.18M
    Foreign exchange effects
    -€18.99K
    Net change in cash
    €5.26M
    Cash at end of period
    €29.66M
    Free cash flow
    -€55.46M

    Balance sheet

    Cash and cash equivalents
    €29.66M
    Cash and short-term investments
    €87.04M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.33M
    Total current assets
    €90.36M
    Property, plant & equipment
    €3.23M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €581.69K
    Total non-current assets
    €3.82M
    Total assets
    €94.18M
    Accounts payable
    €998.53K
    Short-term debt
    €7.85M
    Other current liabilities
    €3.54M
    Total current liabilities
    €12.40M
    Long-term debt
    €296.88K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €2.27M
    Total non-current liabilities
    €2.56M
    Total liabilities
    €14.96M
    Common stock
    €6.04K
    Retained earnings
    -€401.10M
    Other equity
    -€230.43K
    Total equity
    €79.21M
    Total liabilities and shareholders' equity
    €94.18M

    Company information

    Market capitalization
    €27.67M
    Employees
    55
    Enterprise Value
    €7.50M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -77.1% Much better than peer group: -262.8%
    ROA
    -64.9% Much worse than peer group: -33.0%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -200.7%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.11M

    Notifications